Jovanovic Marija N,Topic Vucenovic Valentina,Roganovic Masa I,Pavlovic Gordana,Kralj Djordje,Markovic Srdjan T,Svorcan Petar V,Vucicevic Katarina M (2026) Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease, PHARMACEUTICS, vol. 18, br. 7, str. - (Article) 

Homsek-Ilic Ana,Jovanovic Marija N,Markovic Srdjan T,Vezmar-Kovacevic Sandra D,Knezevic-Ivanovski Tamara,Kralj Djordje,Svorcan Petar V,Vucicevic Katarina M (2026) Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing, PLOS ONE, vol. 21, br. 7, str. - (Article) 

Golubovic Olga,Knezevic-Ivanovski Tamara,Kralj Djordje,Mitrovic Milos,Milic Aleksandar,Svorcan Petar V,Markovic Srdjan T (2026) Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience, CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, vol. 19, br. , str. - (Article) 

Kralj Djordje,Maksic Mladen M,Knezevic-Ivanovski Tamara,Odanovic Olga,Maksic Tijana,Gmizic Tijana,Ivosevic Zeljko,Radojevic Dusan N,Suljic Lejla,Todorovic Nevena,Zdravkovic Natasa D,Corovic Irfan F,Markovic Srdjan T (2026) Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence, BIOMEDICINES, vol. 14, br. 3, str. - (Review) 

Kralj Djordje,Paravina N,Markovic S,Knezevic Tamara,Jovanovic M,Sreckovic Slobodan,Kalaba Ana,Vucicevic Katarina M (2026) Association of Post-Induction Ustekinumab levels with treatment response in inflammatory bowel disease patients, JOURNAL OF CROHNS & COLITIS, vol. 20, br. , str. - (Meeting Abstract) 

Mitrovic M,Knezevic Tamara,Odanovic Olga,Andrej S,Kalaba Ana,Kralj Djordje,Markovic S (2026) Advanced Therapies Reshape Liver Steatosis Outcomes in Inflammatory Bowel Disease: A Prospective Cohort Analysis, JOURNAL OF CROHNS & COLITIS, vol. 20, br. , str. - (Meeting Abstract) 

Mitrovic M,Knezevic Tamara,Kalaba Ana,Odanovic Olga,Kralj Djordje,Markovic S (2026) Human Papillomavirus Epidemiology in Anti-TNFα-Treated Women: Contrasting Patterns Between Inflammatory Bowel Disease Patients and Rheumatoid Arthritis, JOURNAL OF CROHNS & COLITIS, vol. 20, br. , str. - (Meeting Abstract) 

Knezevic Tamara,Matic Rade G,Odanovic Olga,Mitrovic M,Kalaba Ana,Kralj Djordje,Markovic S (2026) Building Serbia's First IBD Data Warehouse: Early Results from Serbia's BIOTHER IBD Platform, JOURNAL OF CROHNS & COLITIS, vol. 20, br. , str. - (Meeting Abstract) 

Knezevic-Ivanovski Tamara,Milic-Perovic Marija,Stopic Bojan,Golubovic Olga,Kralj Djordje,Mitrovic Milos,Sreckovic Slobodan,Dobrosavljevic Ana,Svorcan Petar V,Markovic Srdjan T (2025) Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study, BIOMEDICINES, vol. 13, br. 8, str. - (Article) 

Milenkovic Bojana R,Vezmar-Kovacevic Sandra D,Markovic Srdjan T,Jovanovic Marija N,Knezevic-Ivanovski Tamara,Kralj Djordje,Svorcan Petar V,Miljkovic Branislava R,Vucicevic Katarina M (2025) Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis, PHARMACEUTICALS, vol. 18, br. 8, str. - (Article) 

Markovic Srdjan T,Kralj Djordje,Knezevic-Ivanovski Tamara,Svorcan Petar V (2025) Telehealth-An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease, MEDICINA-LITHUANIA, vol. 61, br. 2, str. - (Article) 

Markovic Srdjan T,Kralj Djordje,Knezevic-Ivanovski Tamara,Kalaba Ana,Odanovic Olga,Homsek Ana B,Svorcan Petar V,Vucicevic Katarina M (2025) Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study, JOURNAL OF CROHNS & COLITIS, vol. 19, br. , str. I1231-I1231 (Meeting Abstract) 

Jovanovic Marija N,Homsek Ana B,Markovic Srdjan T,Kralj Djordje,Svorcan Petar V,Knezevic-Ivanovski Tamara,Odanovic Olga,Vucicevic Katarina M (2025) Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability, BIOMEDICINES, vol. 13, br. 1, str. - (Article) 

Markovic Srdjan T,Kralj Djordje,Mitrovic Milos,Knezevic-Ivanovski Tamara,Kalaba Ana,Odanovic Olga,Maksimovic B,Sreckovic Slobodan,Svorcan Petar V (2025) Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ?, JOURNAL OF CROHNS & COLITIS, vol. 19, br. , str. i2065-i2065 (Meeting Abstract) 

Markovic Srdjan T,Kralj Djordje,Knezevic-Ivanovski Tamara,Mitrovic Milos,Odanovic Olga,Brzacki Vesna M,Svorcan Petar V (2024) Anemia in Inflammatory Bowel Diseases Treated by Liposomal Iron, ACTA FACULTATIS MEDICAE NAISSENSIS, vol. 41, br. 4, str. 555-561 (Article) 

Markovic Srdjan T,Kralj Djordje,Svorcan Petar V,Knezevic-Ivanovski Tamara,Odanovic Olga,Obradovic Sanja,Homsek Ana B,Jovanovic Marija N,Savic Rada,Vucicevic Katarina M (2024) Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics, PHARMACEUTICS, vol. 16, br. 12, str. - (Article) 

Brankovic Marija S,Gmizic Tijana,Dukic Marija,Zdravkovic Marija D,Daskalovic Branislava,Mrda Davor,Nikolic Novica,Brajkovic Milica,Gojgic Milan,Lalatovic Jovana,Kralj Djordje,Pantic Ivana L,Vojnovic Marko,Milovanovic Tamara M,Djurasevic Sinisa F,Todorovic Zoran M (2024) Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders, ANTIOXIDANTS, vol. 13, br. 5, str. - (Review) 

Knezevic Tamara,Dobrosavljevic A,Odanovic Olga,Sreckovic Slobodan,Kralj Djordje,Mitrovic Milos,Svorcan Petar V,Markovic Srdjan T (2024) Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study, JOURNAL OF CROHNS & COLITIS, vol. 18, br. , str. I1550-I1550 (Meeting Abstract) 

Mitrovic Milos,Dobrosavljevic Ana,Odanovic Olga,Knezevic-Ivanovski Tamara,Kralj Djordje,Erceg Sanja,Perucica Ana,Svorcan Petar V,Stankovic-Popovic Verica (2024) The Effects of Synbiotics on the Liver Steatosis, Inflammation, and Gut Microbiome of Metabolic Dysfunction-associated Liver Disease Patients-Randomized trial, ROMANIAN JOURNAL OF INTERNAL MEDICINE, vol. 62, br. 2, str. 184-193 (Article) 

Markovic Srdjan T,Kralj Djordje,Odanovic Olga,Homsek Ana B,Kalaba Ana,Svorcan Petar V,Vucicevic Katarina M (2023) Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients, JOURNAL OF CROHNS & COLITIS, vol. 17, br. , str. 925-925 (Meeting Abstract) 

Mitrovic Milos,Markovic Srdjan T,Kalaba Ana,Zaric Dusan,Kralj Djordje,Milic A,Svorcan Petar V (2023) The effect of antiTNF alpha and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease, JOURNAL OF CROHNS & COLITIS, vol. 17, br. , str. 837-837 (Meeting Abstract) 

Knezevic Tamara,Cujic Danica,Odanovic Olga,Kralj Djordje,Gnjatovic Marija Lj,Kalaba Ana,Vrinic-Kalem Dusica,Svorcan Petar V,Markovic Srdjan T (2022) Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination, JOURNAL OF CROHNS & COLITIS, vol. 16, br. , str. I349-I349 (Meeting Abstract) 

Knezevic Tamara,Cujic Danica,Odanovic Olga,Kralj Djordje,Gnjatovic Marija Lj,Kalaba Ana,Vrinic-Kalem Dusica,Svorcan Petar V,Markovic Srdjan T (2022) Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination, JOURNAL OF CROHNS & COLITIS, vol. 16, br. , str. I349-I349 (Meeting Abstract)